Skip to main content
Pulike Biological Engineering,Inc. logo

Pulike Biological Engineering,Inc. — Investor Relations & Filings

Ticker · 603566 ISIN · CNE1000025N0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,080 across all filing types
Latest filing 2021-11-15 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 603566

About Pulike Biological Engineering,Inc.

http://en.pulike.com.cn/

Pulike Biological Engineering, Inc. specializes in the research, development, and production of veterinary biological products and pharmaceutical preparations. The company focuses on animal disease prevention through the manufacture of high-end vaccines, diagnostic reagents, and veterinary medicines. Its product range primarily serves the swine and poultry sectors, featuring advanced biologicals such as genetically engineered vaccines and synthetic peptide products. Pulike maintains a strong emphasis on technological innovation, utilizing national-level research platforms to develop solutions for complex animal health challenges. The company’s core activities encompass the entire value chain from basic biotechnology research to the commercialization of veterinary health solutions, aiming to improve livestock productivity and biosecurity.

Recent filings

Filing Released Lang Actions
关于非公开发行股票摊薄即期回报填补措施及相关主体承诺的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding the risk of dilution of immediate returns due to a non-public issuance of shares and the measures to compensate for this dilution. It includes detailed financial impact analysis, assumptions, risk warnings, necessity and rationality of the issuance, and commitments from controlling shareholders and management. The content focuses on the capital raising activity and its effects on financial metrics, as well as governance and investor protection measures related to the issuance. There is no indication that this is a full annual or interim report, audit report, or earnings release. It is not a simple announcement of a report publication but a substantive disclosure about a capital financing event and related risk disclosures. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2021-11-15 Chinese
关于未来三年（2021-2023年）股东回报规划的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from the company regarding its shareholder return plan for the next three years (2021-2023). It details the principles, conditions, and mechanisms for profit distribution, including cash dividends and stock dividends. The document is a formal announcement of a policy or plan rather than a financial report or detailed financial statements. It does not contain actual financial data or results but outlines future intentions and governance related to shareholder returns. The document length is 2870 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, it fits best into the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2021-11-15 Chinese
关于无需编制前次募集资金使用情况报告的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by a company regarding the non-requirement to prepare a report on the use of previously raised funds. It references regulatory provisions from the China Securities Regulatory Commission about fundraising reporting requirements and states that the previous fundraising occurred more than five years ago, so no report or audit is needed now. The document is short (883 characters) and serves as a formal announcement about compliance with fundraising reporting rules rather than containing financial data or a detailed report. Therefore, it fits best as a Regulatory Filing (RNS) since it is a regulatory compliance announcement that does not fit other specific categories like Capital/Financing Update (CAP) or Annual Report (10-K).
2021-11-15 Chinese
普莱柯2021年度非公开发行A股股票募集资金使用的可行性分析报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "2021年度非公开发行A股股票募集资金使用的可行性分析报告" which translates to "2021 Annual Non-public Issuance of A Shares Fundraising Feasibility Analysis Report." It details the use plan of funds raised from a non-public stock issuance, including investment projects, amounts, and economic benefits. The content focuses on the feasibility and planned use of capital raised, not on financial results or earnings. It is a detailed report on capital raising and usage, consistent with a Capital/Financing Update. The document length is over 12,000 characters and contains substantive content about fundraising and investment plans, not just an announcement or summary. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2021-11-15 Chinese
第四届监事会第十一次会议决议公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement of resolutions passed by the Supervisory Board of a company regarding a non-public issuance of A shares. It includes specifics about the issuance plan, pricing, number of shares, lock-up periods, use of proceeds, and related approvals. The document is not a full financial report but rather a formal announcement of decisions and plans related to capital raising activities. It references compliance with securities laws and regulatory approvals but does not contain financial statements or earnings data. The content aligns with updates on company fundraising and capital structure changes. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length and detail support a high confidence in this classification.
2021-11-15 Chinese
关于发行对象在本次发行前后六个月内不减持公司股票的承诺公告
Share Issue/Capital Change Classification · 95% confidence The document is a public announcement from a company regarding a commitment by a shareholder (or related party) not to reduce their shareholding within six months before and after a private placement of shares. It involves a non-public issuance of A shares and a pledge not to sell shares during a specified period. This is related to shareholding and capital issuance activities but is not a full financial report or earnings release. It is a specific announcement about shareholding behavior tied to a capital raising event. Therefore, it fits best under the category of Share Issue/Capital Change (SHA). The document is short and focused on a shareholding commitment related to a share issuance, not a report or regulatory filing. Confidence is high due to clear keywords like "非公开发行 A 股股票" (non-public issuance of A shares) and the commitment not to reduce shares around the issuance.
2021-11-15 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.